Integrin αIIbβ3 exists in an activated state in subjects with elevated plasma homocysteine levels

Platelets

Volumn 22, Issue 1, 2011, Pages 63-71

  McGarrigle, Sarah A ^a   O'Neill, Sarah ^a   Walsh, Geraldine M ^a   Moran, Niamh ^a   Graham, Ian M ^b   Cooney, Marie Therese ^b   Monavari, Ahmad ^c   Mayne, Philip ^c   Collins, Patrick ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

^c CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Homocysteine; platelet activation

Indexed keywords

ALPHA2 INTEGRIN; ANTIBODY; BETA3 INTEGRIN; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; DRUG DERIVATIVE; FIBRINOGEN RECEPTOR; INTEGRIN; THIOL DERIVATIVE;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; HYPERHOMOCYSTEINEMIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MODIFICATION; THROMBOCYTE ACTIVATION; ANTIBODY COMBINING SITE; CASE CONTROL STUDY; DRUG EFFECT; FEMALE; MALE; METABOLISM; PATHOPHYSIOLOGY; RISK FACTOR; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOSIS;

ANTIBODIES; BINDING SITES, ANTIBODY; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INTEGRINS; MALE; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN BINDING; RISK FACTORS; SULFHYDRYL COMPOUNDS; THROMBOSIS;

EID: 78651495336     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2010.512646     Document Type: Article

References (38)

1. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-1781.
2. Dawson PA, Cox AJ, Emmerson BT, Dudman NP, Kraus JP, Gordon RB. Characterisation of five missense mutations in the cystathionine beta-synthase gene from three patients with B6-nonresponsive homocystinuria. Eur J Hum Genet 1997;5:15-21.
3. Hu FL, Gu Z, Kozich V, Kraus JP, Ramesh V, Shih VE. Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet 1993;2:1857-1860.
4. McCully KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-128.
5. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991;324:1149-1155.
6. Wald DS, Wald NJ, Morris JK, Law M. Folic acid, homocysteine, and cardiovascular disease: Judging causality in the face of inconclusive trial evidence. BMJ 2006;333:1114-1117.
7. Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 1997;20:295-300.
8. den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-62.
9. Mangoni AA, Jackson SH. Homocysteine and cardiovascular disease: Current evidence and future prospects. Am J Med 2002;112:556-565.
10. Jacobsen DW, Gatautis VJ, Green R, Robinson K, Savon SR, Secic M, Ji J, Otto JM, Taylor Jr LM. Total plasma homocysteine: The mediator/marker controversy continues. Clin Chem 2009;55:1742-1743.
11. Sass JO, Nakanishi T, Sato T, Sperl W, Shimizu A. S-homocysteinylation of transthyretin is detected in plasma and serum of humans with different types of hyperhomocysteinemia. Biochem Biophys Res Commun 2003;310:242-246.
12. Majors AK, Sengupta S, Willard B, Kinter MT, Pyeritz RE, Jacobsen DW. Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin. Arterioscler Thromb Vasc Biol 2002;22:1354-1359.
13. Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 1996;88:907-914.
14. Kamata T, Ambo H, Puzon-McLaughlin W, Tieu KK, Handa M, Ikeda Y, Takada Y. Critical cysteine residues for regulation of integrin alphaIIbbeta3 are clustered in the epidermal growth factor domains of the beta3 subunit. Biochem J 2004;378:1079-1082.
15. MacIntyre DE, Gordon JL. Evidence for two populations of disulphide bonds on blood platelets. Biochem Soc Trans. 1974;2:873.
16. Peerschke EI. Regulation of platelet aggregation by postfibrinogen binding events. Insights provided by dithiothreitoltreated platelets. Thromb Haemost 1995;73:862-867.
17. Sun QH, Liu CY, Wang R, Paddock C, Newman PJ. Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes. Blood 2002;100:2094-2101.
18. Yan B, Smith JW. A redox site involved in integrin activation. J Biol Chem 2000;275:39964-39972.
19. Zucker MB, Masiello NC. Platelet aggregation caused by dithiothreitol. Thromb Haemost 1984;51:119-124.
20. Lahav J, Jurk K, Hess O, Barnes MJ, Farndale RW, Luboshitz J, Kehrel BE. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood 2002;100:2472-2478.
21. ONeill S, Robinson A, Deering A, Ryan M, Fitzgerald DJ, Moran N. The platelet integrin alphaIIb beta3 has an endogenous thiol isomerase activity. J Biol Chem 2000;275:36984-36990.
22. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995;41:991-994.
23. Lauricella AM, Quintana I, Castanon M, Sassetti B, Kordich L. Influence of homocysteine on fibrin network lysis. Blood Coagul Fibrinolysis 2006;17:181-186.
24. Sauls DL, Wolberg AS, Hoffman M. Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: Implications for the mechanism of thrombosis in hyperhomocysteinemia. J Thromb Haemost 2003;1:300-306.
25. Skurk C, Walsh K. Death receptor induced apoptosis: A new mechanism of homocysteine-mediated endothelial cell cytotoxicity. Hypertension 2004;43:1168-1170.
26. Zhang C, Kawauchi J, Adachi MT, Hashimoto Y, Oshiro S, Aso T, Kitajima S. Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochem Biophys Res Commun 2001;289: 718-724.
27. Leoncini G, Pascale R, Signorello MG. Effects of homocysteine on l-arginine transport and nitric oxide formation in human platelets. Eur J Clin Invest 2003;33:713-719.
28. Mutus B, Rabini RA, Staffolani R, Ricciotti R, Fumelli P, Moretti N, Martarelli D, Mazzanti L. Homocysteineinduced inhibition of nitric oxide production in platelets: A study on healthy and diabetic subjects. Diabetologia 2001;44:979-982.
29. Riba R, Nicolaou A, Troxler M, Homer-Vaniasinkam S, Naseem KM. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Atherosclerosis 2004;175:69-75.
30. Spencer CG, Martin SC, Felmeden DC, Blann AD, Beevers GD, Lip GY. Relationship of homocysteine to markers of platelet and endothelial activation in high risk hypertensives: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Int J Cardiol 2004;94:293-300.
31. Graeber JE, Slott JH, Ulane RE, Schulman JD, Stuart MJ. Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism. Pediatr Res 1982;16:490-493.
32. Signorello MG, Pascale R, Leoncini G. Effect of homocysteine on arachidonic acid release in human platelets. Eur J Clin Invest 2002;32:279-284.
33. Olas B, Kedzierska M, Wachowicz B. Comparative studies on homocysteine and its metabolite-homocysteine thiolactone action in blood platelets in vitro. Platelets 2008;19:520-527.
34. Durand P, Lussier-Cacan S, Blache D. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 1997;11:1157-1168.
35. Fuglsang J, Stender M, Zhou J, Moller J, Falk E, Ravn HB. Platelet activity and in vivo arterial thrombus formation in rats with mild hyperhomocysteinaemia. Blood Coagul Fibrinolysis 2002;13:683-689.
36. Mohan IV, Jagroop IA, Mikhailidis DP, Stansby GP. Homocysteine activates platelets in vitro. Clin Appl Thromb Hemost 2008;14:8-18.
37. Sundaramoorthy E, Maiti S, Brahmachari SK, Sengupta S. Predicting protein homocysteinylation targets based on dihedral strain energy and pKa of cysteines. Proteins 2008;71:1475-1483.
38. Walsh GM, Sheehan D, Kinsella A, Moran N, ONeill S. Redox modulation of integrin [correction of integin] alpha IIb beta 3 involves a novel allosteric regulation of its thiol isomerase activity. Biochemistry 2004;43:473-480.